IRLAB Therapeutics Dirección
Dirección controles de criterios 2/4
El CEO de IRLAB Therapeutics' es Gunnar Olsson, nombrado en Feb 2023, tiene una permanencia de 1.17 años. posee directamente un 0.008% de las acciones de la empresa, con un valor de SEK49.59K. La antigüedad media del equipo directivo y de la junta directiva es de 11.3 años y 1.9 años, respectivamente.
Información clave
Gunnar Olsson
Chief Executive Officer (CEO)
kr516.7k
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | 1.3yrs |
Participación del CEO | 0.008% |
Permanencia media de la dirección | 11.3yrs |
Promedio de permanencia en la Junta Directiva | 2yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation
Jan 04Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely
Sep 21We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully
Mar 18IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans
Dec 01We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit
May 19We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Sep 11We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Apr 30What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Mar 19We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth
Jan 25Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay
Dec 21What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Nov 25CEO
Gunnar Olsson (70 yo)
1.3yrs
Permanencia
kr516,666
Compensación
Mr. Gunnar Olsson has been a Director at IRLAB Therapeutics AB (publ) since 2017 and served as its Chairman since May 7, 2020 until February 2023 and is its Interim Chief Executive Officer since February 2...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Interim CEO & Director | 1.3yrs | kr516.67k | 0.0077% SEK 43.8k | |
Executive VP and Head of R&D | no data | kr1.70m | 2.62% SEK 14.9m | |
Chief Financial Officer | 7.3yrs | sin datos | 0.45% SEK 2.6m | |
Chief Scientific Officer | 11.3yrs | sin datos | 1.46% SEK 8.3m | |
Chief Information Officer and Director of Computational Chemistry & Biology | 11.3yrs | sin datos | 0.50% SEK 2.9m | |
Global IR & Communications | no data | sin datos | sin datos | |
Head of Finance & Human Resource and Director of Accounting & Human Resources | 11.3yrs | sin datos | 0.70% SEK 4.0m | |
Chief Medical Officer | 11.3yrs | kr5.00k | 1.33% SEK 7.6m |
11.3yrs
Permanencia media
61.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de IRLAB A es experimentado (11.3 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Interim CEO & Director | 7.3yrs | kr516.67k | 0.0077% SEK 43.8k | |
Independent Director | 8.3yrs | kr325.00k | 0.081% SEK 458.8k | |
Independent Chairman of the Board | 6.3yrs | kr310.00k | 0.019% SEK 109.5k | |
Director | less than a year | sin datos | sin datos | |
Independent Director | less than a year | sin datos | sin datos | |
Independent Director | 2yrs | kr326.67k | sin datos | |
Director | less than a year | sin datos | 8.68% SEK 49.3m |
2.0yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: La junta directiva de IRLAB A no se considera experimentada (1.9 años de permanencia promedio), lo que sugiere una nueva junta directiva.